YB18

YB18 inhibits the growth of P. aeruginosa ATCC 27853, E. coli MG1655, K. pneumoniae ATCC 700603, and A. baumannii ATCC 19606, with MIC values of 16, 8, 8, and 16 μM, and MBC values of 16, 32, 128, and 64 μM, respectively^[1].
YB18 (8-64 μM; 18 h) inhibits the growth of clinically isolated Gram-negative strains, with MIC values ranging from 8 to 64 μM against *E. coli*, *K. pneumoniae*, *P. aeruginosa* and *A. baumannii* strains^[1].
YB18 (2-256 μM; 1 h) exhibits low hemolytic activity against rat red blood cells, with a hemolysis rate of less than 1% even at a concentration as high as 256 μM^[1].
YB18 (2-64 μM; 24 h) exhibits favorable cytocompatibility with RAW 264.7, L929, and NIH 3T3 cells at antibacterial relevant concentrations of 8-16 μM, whereas reduced cell viability is observed at higher concentrations^[1].
YB18 (0-120 min) shows limited stability in 25% rat serum, retaining only 5% of its initial concentration after 120 min of incubation^[1].
YB18 (6-15 mM) forms a viscoelastic hydrogel at a concentration of 12 mM in 0.8× PBS, which exhibits stable gel-like mechanical properties, partial self-recovery behavior, and a dense fibrous self-assembled microstructure^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.